AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16799877 — intervention group
Group type: EXPERIMENTAL
Intervention: Niobium stent (VELA STF)
Number of subjects: 65
Study 16799877 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stent (Antares STF)
Number of subjects: 65
Study 15178172 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic oculomotor tasks (overlap task)
Number of subjects: 8
Study 15178172 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory tasks (everyday scenes and search task)
Number of subjects: 8
Study 15178172 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory tasks (search task)
Number of subjects: 8
Study 15178172 — intervention group
Group type: COMPARATOR
Intervention: Control group (16 healthy volunteers)
Number of subjects: 8
Study 11141871 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (education with interviews)
Number of subjects: 105
Study 11141871 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (interviews only)
Number of subjects: 105
Study 11141871 — intervention group
Group type: COMPARATOR
Intervention: Group 3 (one interview only, control)
Number of subjects: 105
Study 9170774 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention based on social cognitive theory
Number of subjects: 90
Study 9170774 — intervention group
Group type: COMPARATOR
Intervention: Intervention based on the theory of gender and power
Number of subjects: 90
Study 9170774 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 90
Study 8224655 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (continuous administration to reduce resting heart rate by 25%)
Number of subjects: 116
Study 8224655 — intervention group
Group type: COMPARATOR
Intervention: Sclerotherapy (weekly intravariceal sessions using 5% ethanolamide oleate until varices disappeared)
Number of subjects: 116
Study 3809993 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemoccult‐II screening with written invitations and prestamped envelopes
Number of subjects: 60000
Study 3809993 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopy following positive tests
Number of subjects: 60000
Study 30227246 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced education (educational pamphlets and videos for adults, including a 3-minute informational video on screening day)
Number of subjects: 1243
Study 30227246 — intervention group
Group type: COMPARATOR
Intervention: Standard education (no additional educational materials provided)
Number of subjects: 1243
Study 26998789 — intervention group
Group type: EXPERIMENTAL
Intervention: STARTS (enhanced cognitive behavioral intervention)
Number of subjects: 300
Study 26998789 — intervention group
Group type: COMPARATOR
Intervention: SUPPORT (supportive, time and attention-controlled comparison)
Number of subjects: 300
Study 26998789 — intervention group
Group type: EXPERIMENTAL
Intervention: Both STARTS and SUPPORT
Number of subjects: 300
Study 26881516 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy with cisplatin (Arm A)
Number of subjects: 60
Study 26881516 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant boost therapy with cisplatin (Arm B)
Number of subjects: 60
Study 23334177 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser + mitomycin C + silicone intubation (Group 1)
Number of subjects: 80
Study 23334177 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser + silicone intubation (Group 2)
Number of subjects: 80
Study 23334177 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser + mitomycin C (Group 3)
Number of subjects: 80
Study 21859919 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain information booklet and instruction on infant comforting techniques
Number of subjects: 169
Study 21859919 — intervention group
Group type: COMPARATOR
Intervention: Generic NICU care booklet alone
Number of subjects: 169
Study 19081394 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 230
Study 19081394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 230
Study 16870801 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation
Number of subjects: 0
Study 16870801 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid supplementation as an adjunct to standard pharmacotherapy
Number of subjects: 0
Study 15295717 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 16 mg
Number of subjects: 23
Study 15295717 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 32 mg
Number of subjects: 23
Study 15295717 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 20 mg
Number of subjects: 23
Study 15295717 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 40 mg
Number of subjects: 23
Study 15295717 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan 16 mg + Lisinopril 20 mg
Number of subjects: 23
Study 11738913 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin 0.3% and dexamethasone 0.1% eyedrops
Number of subjects: 61
Study 11738913 — intervention group
Group type: COMPARATOR
Intervention: Standard formulation of betamethasone and neomycin eyedrops
Number of subjects: 61
Study 15102426 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg ibuprofen
Number of subjects: 66
Study 15102426 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg paracetamol
Number of subjects: 66
Study 15102426 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study 15102426 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (ibuprofen, paracetamol, placebo)
Number of subjects: 66
Study 8124315 — intervention group
Group type: EXPERIMENTAL
Intervention: THINKable program (computer-assisted attention and memory retraining)
Number of subjects: 15
Study 2680896 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (2 g twice at an interval of two days)
Number of subjects: 241
Study 2680896 — intervention group
Group type: COMPARATOR
Intervention: Placebo (inert but identical tablets)
Number of subjects: 241
Study 940718 — intervention group
Group type: EXPERIMENTAL
Intervention: Trained mothers providing consistent and authentic history of a child's common medical problem during interviews.
Number of subjects: 0
Study 940718 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluative feedback session after videotaped interviews.
Number of subjects: 0
Study 940718 — intervention group
Group type: COMPARATOR
Intervention: Control group of students who did not interview trained mothers or receive evaluative feedback.
Number of subjects: 0
Study 31746218 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 1551
Study 28757232 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected music
Number of subjects: 94
Study 28757232 — intervention group
Group type: EXPERIMENTAL
Intervention: Classical music
Number of subjects: 94
Study 28757232 — intervention group
Group type: EXPERIMENTAL
Intervention: Uplifting piece of their own choice
Number of subjects: 94
Study 28757232 — intervention group
Group type: COMPARATOR
Intervention: Acoustic control stimulus (white noise)
Number of subjects: 94
Study 26630643 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release niacin (ER-niacin)
Number of subjects: 38
Study 26630643 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 25424627 — intervention group
Group type: EXPERIMENTAL
Intervention: Biphasic insulin aspart 30 (BIAsp 30)
Number of subjects: 8578
Study 22238470 — intervention group
Group type: EXPERIMENTAL
Intervention: Miltefosine (1.8‐2.5 mg/kg/d for 28 days; by mouth)
Number of subjects: 116
Study 22238470 — intervention group
Group type: COMPARATOR
Intervention: Meglumine antimoniate (20 mg Sb/kg/d for 20 days; intramuscular)
Number of subjects: 116
Study 20921440 — intervention group
Group type: EXPERIMENTAL
Intervention: Perhexiline 100 mg (n=24)
Number of subjects: 46
Study 20921440 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=22)
Number of subjects: 46
Study 18023436 — intervention group
Group type: EXPERIMENTAL
Intervention: Birefringent sperm selection
Number of subjects: 112
Study 18023436 — intervention group
Group type: COMPARATOR
Intervention: Conventional ICSI
Number of subjects: 112
Study 16186274 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting insulin concentration
Number of subjects: 51
Study 16186274 — intervention group
Group type: EXPERIMENTAL
Intervention: HOMA
Number of subjects: 51
Study 16186274 — intervention group
Group type: EXPERIMENTAL
Intervention: QUICKI
Number of subjects: 51
Study 16186274 — intervention group
Group type: EXPERIMENTAL
Intervention: McAuley's index
Number of subjects: 51
Study 16186274 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting triglyceride concentration
Number of subjects: 51
Study 16186274 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI
Number of subjects: 51
Study 12634666 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal pH of 5.0 or greater
Number of subjects: 6838
Study 12634666 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal pH of 4.5 or greater and Gram stain score of 9 to 10
Number of subjects: 6838
Study 12634666 — intervention group
Group type: COMPARATOR
Intervention: Vaginal pH of less than 4.4 or 4.7
Number of subjects: 6838
Study 10618544 — intervention group
Group type: EXPERIMENTAL
Intervention: Engerix-B 10 microg vaccine (EB)
Number of subjects: 2255
Study 10618544 — intervention group
Group type: COMPARATOR
Intervention: Recombivax-HB 2.5 microg (RB)
Number of subjects: 2255
Study 9093239 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiretroviral treatment and therapy for opportunistic infections
Number of subjects: 0
Study 9093239 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-associated non-Hodgkin lymphomas treatment
Number of subjects: 0
Study 9093239 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-associated central nervous system lymphomas treatment
Number of subjects: 0
Study 9093239 — intervention group
Group type: EXPERIMENTAL
Intervention: Hodgkin's disease treatment in HIV-infected individuals
Number of subjects: 0
Study 8292067 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteric coated multiple-unit formulation (Diclo-Puren 50)
Number of subjects: 18
Study 8292067 — intervention group
Group type: COMPARATOR
Intervention: Single-unit dosage form (reference)
Number of subjects: 18
Study 2880294 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (40 mg per kilogram of body weight per day) with decongestant-antihistamine
Number of subjects: 518
Study 2880294 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin (40 mg per kilogram of body weight per day) without decongestant-antihistamine
Number of subjects: 518
Study 2880294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 518
Study 30691293 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Compassion Scale Short Form (SCS-SF)
Number of subjects: 594
Study 29087443 — intervention group
Group type: COMPARATOR
Intervention: Usual treatment included in the programme (Group A)
Number of subjects: 249
Study 29087443 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual treatment plus attendance at self-help groups (Group B)
Number of subjects: 249
Study 27884169 — intervention group
Group type: EXPERIMENTAL
Intervention: TeachTown: Basics, a computer-assisted intervention for students with autism
Number of subjects: 70
Study 24948384 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula-fed infants
Number of subjects: 213
Study 24948384 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental control of feeding
Number of subjects: 213
Study 24948384 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental pressure to eat
Number of subjects: 213
Study 24948384 — intervention group
Group type: COMPARATOR
Intervention: Breast-fed infants
Number of subjects: 213
Study 20176444 — intervention group
Group type: EXPERIMENTAL
Intervention: Looming imagery condition
Number of subjects: 72
Study 20176444 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 72
Study 19164818 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face support
Number of subjects: 66
Study 19164818 — intervention group
Group type: COMPARATOR
Intervention: Telephone support
Number of subjects: 66
Study 19164818 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Face-to-face and Telephone)
Number of subjects: 66
Study 16419568 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT scans after i.v. injection of 99mTc‐ECD of 0.3 mCi/kg b.m.
Number of subjects: 30
Study 12591833 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous dalteparin twice daily for three months
Number of subjects: 2267
Study 12591833 — intervention group
Group type: COMPARATOR
Intervention: Placebo for three months
Number of subjects: 2267
Study 10654208 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactate-based hemofiltration (group 1)
Number of subjects: 132
Study 10654208 — intervention group
Group type: COMPARATOR
Intervention: Acetate-based hemofiltration (group 2)
Number of subjects: 132
Study 10654208 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonate-based hemofiltration (group 3)
Number of subjects: 132
Study 8562400 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent claudication patients
Number of subjects: 617
Study 8562400 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 617
Study 9791239 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoridated toothpaste
Number of subjects: 0
Study 9791239 — intervention group
Group type: COMPARATOR
Intervention: Non-fluoridated toothpaste or control group not specified
Number of subjects: 0
Study 2882776 — intervention group
Group type: EXPERIMENTAL
Intervention: Carteolol (beta-adrenoceptor blocker)
Number of subjects: 8
Study 2882776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31726954 — intervention group
Group type: EXPERIMENTAL
Intervention: Circle of Security-Intensive (COS-I) intervention
Number of subjects: 72
Study 31726954 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 72
Study 29072044 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused shock wave therapy
Number of subjects: 32
Study 29072044 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial shock wave therapy
Number of subjects: 32
Study 27595443 — intervention group
Group type: EXPERIMENTAL
Intervention: IIV3 (trivalent inactivated influenza vaccine)
Number of subjects: 15044
Study 27595443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15044
Study 25539757 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral psychotherapy (CBT) for 4 months
Number of subjects: 95
Study 25539757 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual psychology brief psychotherapy (IBPP) for 4 months
Number of subjects: 95
Study 25539757 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT) + olanzapine (5 mg/day) for 3 months
Number of subjects: 95
Study 22998148 — intervention group
Group type: EXPERIMENTAL
Intervention: Excision with inframammary incision (IFI)
Number of subjects: 22
Study 22998148 — intervention group
Group type: COMPARATOR
Intervention: Excision with reduction mammoplasty incision (RMI)
Number of subjects: 22
Study 19212708 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel (45 mg/m²) combined with 5‐FU/leucovorin
Number of subjects: 73
Study 19212708 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan (180 mg/m²) combined with 5‐FU/leucovorin
Number of subjects: 73
Study 19212708 — intervention group
Group type: COMPARATOR
Intervention: Control group not explicitly mentioned
Number of subjects: 73
Study 18991624 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin (10 mg once daily)
Number of subjects: 94
Study 18991624 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (20 mg once daily)
Number of subjects: 94
Study 18991624 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (10 mg once daily)
Number of subjects: 94
Study 18991624 — intervention group
Group type: EXPERIMENTAL
Intervention: All statins
Number of subjects: 94
Study 15829533 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily budesonide therapy
Number of subjects: 225
Study 15829533 — intervention group
Group type: COMPARATOR
Intervention: Intermittent treatment with budesonide
Number of subjects: 225
Study 15829533 — intervention group
Group type: COMPARATOR
Intervention: Daily zafirlukast therapy
Number of subjects: 225
Study 12860943 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiandrogen withdrawal
Number of subjects: 184
Study 10388668 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose treatment
Number of subjects: 0
Study 10388668 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 9282581 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril in combination with bronchodilators, diuretics, antibiotics and/or steroids
Number of subjects: 30
Study 9282581 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment with diuretics, steroids and antibiotics alone
Number of subjects: 30
Study 1713663 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine 5 mg via epidural administration
Number of subjects: 16
Study 1713663 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydromorphone 0.75 mg via epidural administration
Number of subjects: 16
Study 6803519 — intervention group
Group type: EXPERIMENTAL
Intervention: Glibenclamide
Number of subjects: 11
Study 6803519 — intervention group
Group type: EXPERIMENTAL
Intervention: Gliquidone
Number of subjects: 11
Study 6803519 — intervention group
Group type: COMPARATOR
Intervention: Diet period
Number of subjects: 11
Study 31121887 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 54
Study 31121887 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 54
Study 28774269 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination (BCG 1331 SSI)
Number of subjects: 492
Study 26606429 — intervention group
Group type: COMPARATOR
Intervention: LIFT
Number of subjects: 235
Study 26606429 — intervention group
Group type: EXPERIMENTAL
Intervention: LIFT-plug
Number of subjects: 235
Study 24711552 — intervention group
Group type: EXPERIMENTAL
Intervention: Exemestane (25 mg per day)
Number of subjects: 4560
Study 24711552 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4560
Study 22011640 — intervention group
Group type: EXPERIMENTAL
Intervention: Blackcurrant (BC) juice
Number of subjects: 0
Study 22011640 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 20329618 — intervention group
Group type: EXPERIMENTAL
Intervention: Zengjing Capsule No. 1 (ZJC1)
Number of subjects: 72
Study 20329618 — intervention group
Group type: COMPARATOR
Intervention: Wuzi Yanzong Pill (WYP)
Number of subjects: 72
Study 17259038 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-feeding before, during, and after the injection
Number of subjects: 66
Study 17259038 — intervention group
Group type: COMPARATOR
Intervention: Routine clinic procedure (no breast-feeding)
Number of subjects: 66
Study 17259038 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast-feeding
Number of subjects: 66
Study 15341217 — intervention group
Group type: EXPERIMENTAL
Intervention: Tensotremorography used to record voluntary forces
Number of subjects: 0
Study 15341217 — intervention group
Group type: COMPARATOR
Intervention: Conditions of visual feedback
Number of subjects: 0
Study 11594407 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerivastatin 0.8 mg
Number of subjects: 1170
Study 11594407 — intervention group
Group type: COMPARATOR
Intervention: Cerivastatin 0.4 mg
Number of subjects: 1170
Study 11594407 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 40 mg
Number of subjects: 1170
Study 9772309 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin 5 mg
Number of subjects: 20
Study 9772309 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 7527565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) 5‐hydroxyindoleacetic acid (5‐HIAA)
Number of subjects: 29
Study 7527565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) homovanillic acid (HVA)
Number of subjects: 29
Study 7527565 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) 3‐methoxy‐4‐hydroxyphenylglycol (MHPG)
Number of subjects: 29
Study 2658640 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin 1 g
Number of subjects: 46
Study 2658640 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime 1 g
Number of subjects: 46
Study 2658640 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 1 g
Number of subjects: 46
Study 2658640 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 46
Study 2658640 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefuroxime and Ceftazidime
Number of subjects: 46
Study 51285 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (mean 46.9 mg daily)
Number of subjects: 28
Study 51285 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 51285 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine
Number of subjects: 28
Study 31648067 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive training model (group A)
Number of subjects: 1282
Study 31648067 — intervention group
Group type: COMPARATOR
Intervention: Lecture-based training model (group B)
Number of subjects: 1282
Study 31648067 — intervention group
Group type: COMPARATOR
Intervention: Video instruction training model (group C)
Number of subjects: 1282
Study 30998223 — intervention group
Group type: EXPERIMENTAL
Intervention: Evident frustration comment
Number of subjects: 357
Study 30998223 — intervention group
Group type: COMPARATOR
Intervention: Ambiguous comment
Number of subjects: 357
Study 28069685 — intervention group
Group type: EXPERIMENTAL
Intervention: Rolofylline
Number of subjects: 2033
Study 28069685 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2033
Study 26488347 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 40 mg/day (bulimic patients)
Number of subjects: 94
Study 26488347 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine 20 mg/day (non-bulimic patients)
Number of subjects: 94
Study 26488347 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 94
Study 23726516 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat talk vignette
Number of subjects: 116